BHI News Section Archives - Page 47 of 1201

News

May 6, 2024

NIH Entrepreneurship Bootcamp

The NIH Entrepreneurship Bootcamp is designed to equip life science investigators and nascent companies with specialized innovation and entrepreneurship training.…

Andy

Love0

News

May 6, 2024

Meet with… Johnson & Johnson’s Immunology Team on May 21st

Join us for Meet With…Johnson & Johnson’s Immunology Team at JLABS @ Washington, DC on May 21.During Digestive Disease Week…

Andy

Love0

News

May 6, 2024

Washington DC’s Nanochon closes $4M Series Seed Prime

WASHINGTON--(BUSINESS WIRE)--Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round.…

Andy

Love0

News

May 6, 2024

Publication Announcement: Welldoc Shares Clinical Research on AI and Weight Management

welldoc® recently presented a new clinical research paper at the 14th annual Conference on Health IT and Analytics (CHITA) in…

Andy

Love0

News

May 6, 2024

Bethesda’s AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)

BETHESDA, Md., May 06, 2024 (GLOBE NEWSWIRE) -- AsclepiX Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging computational biology from Johns…

Andy

Love0

News

May 6, 2024

Rockville’s GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory…

Andy

Love0

News

May 6, 2024

BioSolution Designs Announces Formation of BeatBio Subsidiary to Develop Complex Multigenic Cardiovascular Therapies

FREDERICK, MD, UNITED STATES, May 1, 2024 /EINPresswire.com/ -- BioSolution Designs is pleased to announce the formation of its first…

Andy

Love0

News

May 6, 2024

ARPA-H Sprinting toward solutions for women’s health

The ARPA-H Sprint for Women’s Health is a funding opportunity to address critical unmet challenges in women’s health, championing transformative innovations and…

Andy

Love0

News

May 2, 2024

BISNOW: Maryland Life Sciences Seeks To Shift Away From ‘A World Of Office Parks’

May 2, 2024, Emily Wishingrad, Washington, D.C. Maryland’s life sciences market, one of the largest in the country, has a…

Andy

Love0

News

May 2, 2024

BioSolution Designs & RoosterBio Announce Collaboration on Genetically Modified MSCs for Biotherapeutic Development

Frederick, MD, May 2, 2024 – BioSolution Designs (BSD), a biotechnology invention studio developing proprietary platforms for multigenic gene and…

Andy

Love0

BHI News Section

NIH Entrepreneurship Bootcamp

Meet with… Johnson & Johnson’s Immunology Team on May 21st

Washington DC’s Nanochon closes $4M Series Seed Prime

Publication Announcement: Welldoc Shares Clinical Research on AI and Weight Management

Bethesda’s AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)

Rockville’s GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

BioSolution Designs Announces Formation of BeatBio Subsidiary to Develop Complex Multigenic Cardiovascular Therapies

ARPA-H Sprinting toward solutions for women’s health

BISNOW: Maryland Life Sciences Seeks To Shift Away From ‘A World Of Office Parks’

BioSolution Designs & RoosterBio Announce Collaboration on Genetically Modified MSCs for Biotherapeutic Development

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search